Nitrite and nitrate-dependent generation of anti-inflammatory fatty acid nitroalkenes
Open accessAbstract
A gap in our understanding of the beneficial systemic responses to dietary constituents nitrate (NO3−), nitrite (NO2−) and conjugated linoleic acid (cLA) is the identification of the downstream metabolites that mediate their actions. To examine these reactions in a clinical context, investigational drug preparations of 15N-labeled NO3− and NO2− were orally administered to healthy humans with and without cLA. Mass spectrometry analysis of plasma and urine indicated that the nitrating species nitrogen dioxide was formed and reacted with the olefinic carbons of unsaturated fatty acids to yield the electrophilic fatty acid, nitro-cLA (NO2-cLA). These species mediate the post-translational modification (PTM) of proteins via reversible Michael addition with nucleophilic amino acids. The PTM of critical target proteins by electrophilic lipids has been described as a sensing mechanism that regulates adaptive cellular responses, but little is known about the endogenous generation of fatty acid nitroalkenes and their metabolites. We report that healthy humans consuming 15N-labeled NO3− or NO2−, with and without cLA supplementation, produce 15NO2-cLA and corresponding metabolites that are detected in plasma and urine. These data support that the dietary constituents NO3−, NO2− and cLA promote the further generation of secondary electrophilic lipid products that are absorbed into the circulation at concentrations sufficient to exert systemic effects before being catabolized or excreted.
AI snapshot
Written from the paper’s full text.
TL;DR
In healthy humans, oral 15N-labeled nitrate or nitrite, with and without conjugated linoleic acid (cLA), generated 15NO2-cLA and related metabolites detectable in plasma and urine. These findings support that dietary nitrate, nitrite, and cLA produce absorbable electrophilic fatty acid nitroalkenes at concentrations proposed to exert systemic signaling effects.
Key findings
- Without cLA supplementation, endogenous 14NO2-cLA was present in all volunteers and did not vary significantly over 24 h; 15NO2-cLA was not detectable after 15NO2− supplementation and was only detectable 24 h after 15NO3− consumption (0.14 nM median, range 0–25.3 nM).
- With cLA supplementation, 15NO2-cLA became detectable at 1 h after 15NO2− + cLA (2.5 nM median, range 0–25.7 nM) and remained elevated until 6 h (3.3 nM median, range 0–11.5 nM); after 15NO3− + cLA it became detectable at 2 h and was greatest at 24 h (1.6 nM median, range 0–9.9 nM).
- Plasma cLA isomers peaked at 3 h after 15NO2− + cLA: (9Z,11E)-cLA averaged 858 ± 138 nM (range 530–1350 nM) and (10E,12Z)-cLA averaged 430.3 ± 77.8 nM (range 271–710 nM).
- Urinary 15NO2-cLA was greatest 6 h after 15NO2− + cLA (10.7 pmol/mg creatinine median, range 0–55.0) and 24 h after 15NO3− + cLA (12.5 pmol/mg creatinine median, range 3.8–44.3); Cys-15NO2-cLA metabolites were ~10-fold greater than Cys-14NO2-cLA at 24 h.
Methods
- Healthy volunteers (3 males, 2 females, mean age 29 ± 7 yr) fasted overnight and were randomized to receive oral Na15NO2 (20 mg) or Na15NO3 (1 gm), then crossed over after ~7 days to the other nitrogen oxide (Trial I). In Trial II, the same 5 volunteers received cLA (3 gm) concurrently with both NOx; blood was drawn at baseline, 0.5, 1, 2, 3, 6, and 24 h, and urine was collected at baseline, 6, and 24 h for Trial II only.
- Plasma and urine were analyzed by LC-MS/MS for 14NO2-cLA and 15NO2-cLA after lipid extraction; nitrite was measured by triiodide chemiluminescence and by diaminonaphthalene derivatization with LC-MS/MS to distinguish 14N/15N contributions; cLA was measured by PTAD derivatization LC-MS/MS.
- Statistical analysis used samples from 5 subjects, with duplicate or triplicate analyses per subject per time point; data are reported as mean ± SEM for plasma cLA and overall 14NO2-cLA, and as median and range for 14NO2-cLA and 15NO2-cLA box plots.
Limitations
- The paper states that detection and quantification of NO2-cLA and other electrophilic fatty acids are challenged by their facile reaction with biological nucleophiles, esterification into complex lipids, enzymatic reduction, oxidation, and mitochondrial β-oxidation; the relative signaling activities of β-oxidation products, extents of NO2-fatty acid esterification into glycerolipids, and half-lives of nitro-fatty acids in complex lipid and tissue compartments remain to be fully characterized.
- Evident from the text: the study included only 5 healthy volunteers with normal blood pressure, so findings may not generalize to other populations; Trial I did not include urine collection; cLA was given only in Trial II; and sampling was limited to 24 h after supplementation.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 52 cited sources checked · 0 supported · 0 flagged
- Findingown data
These changes corresponded with the timing of peak plasma concentrations of both (9Z,11E)-cLA and (10E,12Z)-cLA.
“These changes corresponded with the timing of peak plasma concentrations of both (9Z,11E)-cLA and (10E,12Z)-cLA (Fig. 3A).”
Quote in the paperNot a substantial claim - Findingown data
The consumption of cLA in Trial II supported significant increases in plasma 15NO2-cLA levels from 1 to 6 h following 15NO2− + cLA administration.
“The consumption of cLA in Trial II supported significant increases in plasma 15NO2-cLA levels from 1 to 6 h following 15NO2− + cLA administration (Fig. 2E).”
Quote in the paperSubstantial claim - Findingown data
Mass spectrometry analysis of healthy human urine and plasma at different times after oral consumption of 15N-labeled stable isotopes of NO2− and NO3− and conjugated linoleic acid (cLA) reveals substantial NO2-FA generation at concentrations capable of mediating metabolic and inflammatory signaling responses.
“Herein, the mass spectrometry analysis of healthy human urine and plasma at different times after oral consumption of 15N-labeled stable isotopes of NO2− and NO3− and conjugated linoleic acid (cLA) reveals substantial NO2-FA generation at concentrations capable of mediating metabolic and inflammatory signaling responses.”
Quote in the paperSubstantial claim - Findingown data
Endogenous urinary mean 14NO2-cLA concentrations modestly decreased after 15NO2− + cLA or 15NO3− + cLA supplementation over the 24 h period.
“Endogenous urinary mean 14NO2-cLA concentrations modestly decreased after 15NO2− + cLA or 15NO3− + cLA supplementation over the 24 h period (Fig. 4A).”
Quote in the paperSubstantial claim - Findingown data
The NO2− concentrations after 15NO3− supplementation in Trials I and II peaked between 2 and 3 h with a slightly longer lag time when cLA was added.
“The NO2− concentrations after 15NO3− supplementation in Trials I and II peaked between 2 and 3 h with a slightly longer lag time when cLA was added (Fig. 3C and D).”
Quote in the paperNot a substantial claim
- Findingown data
15NO3− did not contribute as much to the net NO2− concentration as direct administration of 15NO2−.
“As expected, 15NO3− did not contribute as much to the net NO2− concentration as direct administration of 15NO2− (Fig. 3C and D).”
Quote in the paperNot a substantial claim - Findingown data
The peak plasma 15NO2− concentration at 0.5 h preceded the highest 15NO2− + cLA-dependent 15NO2-cLA level, seen at 2 h.
“The peak plasma 15NO2− concentration at 0.5 h preceded the highest 15NO2− + cLA-dependent 15NO2-cLA level, seen at 2 h (Fig. 2E).”
Quote in the paperNot a substantial claim - Findingown data
Plasma 15NO2-cLA concentrations in the 15NO2−-supplemented cohort paralleled plasma cLA concentrations.
“Plasma 15NO2-cLA concentrations in the 15NO2−-supplemented cohort paralleled plasma cLA concentrations (Fig. 2E and 3A).”
Quote in the paperSubstantial claim - Findingown data
The 14NO2− levels were increased in plasma after 15NOx supplementation.
“The 14NO2− levels were increased in plasma after 15NOx supplementation (Fig. 3C and D).”
Quote in the paperNot a substantial claim - Findingown data
With cLA supplementation, greater concentrations of 15NO2-cLA were detected earlier after both 15NO2− and 15NO3− supplementation.
“With cLA supplementation, greater concentrations of 15NO2-cLA were detected earlier after both 15NO2− and 15NO3− supplementation (Fig. 2E).”
Quote in the paperSubstantial claim - Findingcitation
The decrease of 15NO2-cLA in plasma between 6 and 24 h tracked with the plasma half-life of NO2−.
“The plasma half-life of NO2− is 5–6 h, also tracking with the decrease of 15NO2-cLA in plasma between 6 and 24 h [39, 40].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] Wagner, 1983, Metabolic fate of an oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid, Cancer research
Not checked in the free run.
- cites [40] Lundberg, 2008, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nat Rev Drug Discov source
Not checked in the free run.
- Findingown data
Evidence for these reactions occurring in humans was reflected by the detection of urinary 15NO2-cLA β-oxidation products and corresponding cysteine-NO2-cLA and cysteine-NO2-cLA β-oxidation products after 15NOx + cLA supplementation.
“Evidence for these reactions occurring in humans was reflected by the detection of urinary 15NO2-cLA β-oxidation products and corresponding cysteine-NO2-cLA and cysteine-NO2-cLA β-oxidation products detected after 15NOx + cLA supplementation (Supplementary Fig S2 and S3).”
Quote in the paperSubstantial claim - Findingown data
Human plasma NO2-cLA concentrations after 15NOx + cLA supplementation increased from an average basal level of 3 nM to 10 nM.
“Herein, human plasma NO2-cLA concentrations after 15NOx + cLA supplementation increased from an average basal level of 3 nM to 10 nM.”
Quote in the paperSubstantial claim - Premisecitation
NO2-FA display signaling actions that expand both the pharmacokinetics and scope of nitric oxide (·NO) signaling events to include actions beyond the activation of guanylate cyclase-dependent cGMP production.
“NO2-FA display signaling actions that expands both the pharmacokinetics and scope of nitric oxide (·NO) signaling events to include actions beyond the activation of guanylate cyclase-dependent cGMP production [4–7].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [4] Zhang, 2010, Nitro-oleic acid inhibits angiotensin II-induced hypertension, Circ Res source
Not checked in the free run.
- cites [5] Khoo, 2010, Activation of vascular endothelial nitric oxide synthase and heme oxygenase-1 expression by electrophilic nitro-fatty acids, Free Radic Biol Med source
Not checked in the free run.
- cites [6] Kelley, 2014, Fatty acid nitroalkenes ameliorate glucose intolerance and pulmonary hypertension in high-fat diet-induced obesity
Not checked in the free run.
- cites [7] Reddy, 2013, The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease, J Immunol source
Not checked in the free run.
- Premisecitation
The unique electrophilic character of fatty acid nitroalkenes promotes the reversible Michael addition of susceptible cysteines in a limited number of transcriptional regulatory factors and enzymes.
“The unique electrophilic character of fatty acid nitroalkenes promotes the reversible Michael addition of susceptible cysteines in a limited number of transcriptional regulatory factors and enzymes [11].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [11] Schopfer, 2011, Formation and signaling actions of electrophilic lipids, Chem Rev source
Not checked in the free run.
- Premisecitation
Intrinsic to the metabolism of NO3− and NO2− is the formation of the nitrogen dioxide radical (·NO2).
“Intrinsic to the metabolism of NO3− and NO2− is the formation of the nitrogen dioxide radical (·NO2).”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [21] Suarez, 1989, Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum, Cancer research
Not checked in the free run.
- cites [22] Leach, 1987, Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach, Carcinogenesis source
Not checked in the free run.
- cites [23] Eiserich, 1998, Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature source
Not checked in the free run.
- Interpretationreasoning
The lower levels of cLA at later time points may have contributed to the decreased 15NO3−-derived 15NO2-cLA formation.
“The lower levels of cLA at later time points may have contributed to the decreased 15NO3−-derived 15NO2-cLA formation (Fig. 2D and E).”
Quote in the paperNot a substantial claim - Premisecitation
·NO2-induced nitration is several orders of magnitude greater for the conjugated diene system of cLA compared to the bis-allylic diene system found in linoleic and oleic acids due to resonance stabilization of the radical product formed during ·NO2 radical addition.
“·NO2-induced nitration is also several orders of magnitude greater for the conjugated diene system of cLA compared to the bis-allylic diene system found in linoleic and oleic acids due to resonance stabilization of the radical product formed during ·NO2 radical addition [25].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25] Claridge, 1998, The reactions of nitrogen dioxide with dienes, Journal of the Chemical Society - Perkin Transactions source
Not checked in the free run.
- Interpretationcitation
The beneficial clinical responses linked with cLA consumption are due in part to the formation and signaling actions of NO2-cLA.
“The consumption of cLA is linked with beneficial clinical responses, including the reduction of obesity-related body mass index, improved insulin sensitivity and attenuation of airway hyperactivity, all of which we propose are due in part to the formation and signaling actions of NO2-cLA [29–32].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [29] Tricon, 2004, Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans, The American journal of clinical nutrition source
Not checked in the free run.
- cites [30] Tricon, 2004, Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans, The American journal of clinical nutrition source
Not checked in the free run.
- cites [31] MacRedmond, 2010, Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics, Clin Exp Allergy source
Not checked in the free run.
- cites [32] Zulet, 2005, Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health, J Physiol Biochem source
Not checked in the free run.
- Premisereasoning
cLA is the preferable substrate for nitration despite the fact that conjugated dienes are present in ~100-fold lower concentrations than bis-allylic unsaturated fatty acids in plasma.
“This makes cLA the preferable substrate for nitration despite the fact that conjugated dienes are present in ~100-fold lower concentrations than bis-allylic unsaturated fatty acids in plasma [26].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [26] Spiros, 2008, Conjugated linoleic acid content of human plasma, Lipids in health and disease
Not checked in the free run.
- Premisecitation
Synthetic homologs of endogenous nitroalkenes induce human coronary artery endothelium to alter the expression of over 400 genes related to metabolism, tissue repair and inflammatory responses.
“Consequently, synthetic homologs of endogenous nitroalkenes induce human coronary artery endothelium to alter the expression of over 400 genes related to metabolism, tissue repair and inflammatory responses [12].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [12] Kansanen, 2009, Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid, J Biol Chem source
Not checked in the free run.
- Premisecitation
The plasma half-life of NO2− is 5-6 h.
“The plasma half-life of NO2− is 5–6 h, also tracking with the decrease of 15NO2-cLA in plasma between 6 and 24 h [39, 40].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [39] Wagner, 1983, Metabolic fate of an oral dose of 15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid, Cancer research
Not checked in the free run.
- cites [40] Lundberg, 2008, The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics, Nat Rev Drug Discov source
Not checked in the free run.
- Premisecitation
Significant metabolic and anti-inflammatory responses are induced by exogenously-administered fatty acid nitroalkenes in murine models after administration of doses giving 5-10 nM plasma concentrations.
“Significant metabolic and anti-inflammatory responses are induced by exogenously-administered fatty acid nitroalkenes in murine models after administration of doses giving 5–10 nM plasma concentrations [43, 44].”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [43] Villacorta, 2013, Electrophilic nitro-fatty acids inhibit vascular inflammation by disrupting LPS-dependent TLR4 signalling in lipid rafts, Cardiovasc Res source
Not checked in the free run.
- cites [44] Borniquel, 2010, Nitrated oleic acid up-regulates PPARgamma and attenuates experimental inflammatory bowel disease, Free Radic Biol Med source
Not checked in the free run.
- Interpretationreasoning
The consumption of dietary constituents high in NO3− and cLA, such as leafy vegetables, dairy products and meat, can mediate physiological responses via the generation of NO2-cLA.
“These data support the concept that the consumption of dietary constituents high in NO3− and cLA, such as leafy vegetables, dairy products and meat, can mediate physiological responses via the generation of NO2-cLA.”
Quote in the paperSubstantial claim - Premisecitation
Phase 1 safety studies using FDA-approved nitro-oleic acid reveal a wide therapeutic window for NO2-fatty acids.
“Phase 1 safety studies using FDA-approved nitro-oleic acid reveal a wide therapeutic window for NO2-fatty acids (clinicaltrials.gov ID: NCT02127190).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites clinicaltrials.gov ID: NCT02127190
Not checked in the free run.
- May combine two claims. 36
- Classified as probably not a substantial claim. 10
May combine two claims.
Findingown data15NO2-cLA generation became detectable at 1 h after 15NO2− + cLA supplementation and remained elevated until 6 h.
“15NO2-cLA generation became detectable at 1 h (2.5 nM median, range = 0 to 25.7 nM) after 15NO2− + cLA supplementation and remained elevated until 6 h (3.3 nM median, range = 0 to 11.5 nM).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data15NO3− + cLA mediated 15NO2-cLA generation became detectable at 2 h and was greatest at 24 h compared to baseline.
“In contrast, 15NO3− + cLA mediated 15NO2-cLA generation became detectable at 2 h and was the greatest at 24 h (1.6 nM median, range = 0 to 9.9 nM), compared to baseline (Fig. 2E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataEndogenous 14NO2-cLA was present in the plasma of all volunteers and did not vary significantly over the 24 h sampling period after both 15NO2− and 15NO3− supplementation in Trial I.
“Endogenous 14NO2-cLA was present in the plasma of all volunteers and did not vary significantly over the 24 h sampling period after both 15NO2− and 15NO3− supplementation (15NO2−: 1.0 ± 0.3 nM and 15NO3−: 2.1 ± 0.7 nM, Fig. 2B).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn Trial II, similar concentrations of endogenous 14NO2-cLA were detectable over the 24 h sampling period and were not affected by 15NOx + cLA supplementation.
“Similar concentrations of endogenous 14NO2-cLA were detectable over the 24 h sampling period and not affected by 15NOx + cLA supplementation (15NO2− + cLA : 2.6 ± 0.8 nM and 15NO3− + cLA L 3.1 ± 0.9 nM, Fig. 2D).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown data15NO2-cLA was not detectable over the sampling period after 15NO2− supplementation and was only detectable 24 h after 15NO3− consumption in Trial I.
“15NO2-cLA was not detectable over the sampling period after 15NO2− supplementation and was only detectable 24 h after 15NO3− consumption (0.14 nM median, range = 0 to 25.3 nM, Fig. 2C).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThe reactions of oxides of nitrogen support substantial NO2-FA generation in humans, and the levels can be altered by dietary supplementation.
“We now report that the reactions of these oxides of nitrogen support substantial NO2-FA generation in humans, the levels of which can be altered by dietary supplementation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe (9Z,11E)-cLA isomer remained elevated above baseline between 0.5 and 6 h before decreasing back to baseline, while the (10E,12Z)-cLA isomer, derived from the cLA supplement, was only detected from 2 to 6 h.
“The (9Z,11E)-cLA isomer remained elevated above baseline between 0.5 and 6 h before decreasing back to baseline while the (10E,12Z)-cLA isomer, derived from the cLA supplement, was only detected from 2 to 6 h (Fig. 3A).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataCysteine-NO2-cLA adducts were detected in urine, with the ion intensity of Cys-15NO2-cLA metabolites being ~10-fold greater than Cys-14NO2-cLA metabolites at 24 h.
“Cysteine-NO2-cLA adducts were detected in urine, with the ion intensity of Cys-15NO2-cLA metabolites being ~10-fold greater than Cys-14NO2-cLA metabolites at 24 h (Supplementary Fig. S3).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataUrinary 15NO2-cLA levels paralleled 15NO2-cLA levels, peaking at 6 h with an equimolar contribution from 14NOx and 15NOx species.
“This paralleled 15NO2-cLA levels, peaking at 6 h with an equimolar contribution from 14NOx and 15NOx species (Fig. 4C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataTotal urinary NO2− concentrations decreased after 15NO3− + cLA administration over the 24 h time period, with little contribution from 15NO3−.
“Total urinary NO2− concentrations decreased after 15NO3− + cLA administration over the 24 h time period, with little contribution from 15NO3− (Fig. 4C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataPlasma NO2− concentrations were greatest at 0.5 h post-15NO2− supplementation in both trials; total NO2− concentrations were greatest at 0.5 h in Trial I, where there was a larger contribution of 15NO2− to total NO2−.
“Plasma NO2− concentrations were greatest at 0.5 h post-15NO2− supplementation in both trials; however, total NO2− concentrations were greatest at 0.5 h in Trial I, where there was a larger contribution of 15NO2− to total NO2− (Fig. 3C).”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe concentration of urinary 15NO2-cLA was greatest 6 h after 15NO2− + cLA consumption and 24 h after 15NO3− + cLA consumption.
“The concentration of urinary 15NO2-cLA was greatest 6 h after 15NO2− + cLA consumption (10.7 pmol/mg creatinine (Cre) median, range = 0 to 55.0 pmol/mg Cre) and 24 h after 15NO3− + cLA consumption (12.5 pmol/mg Cre median, range = 3.8 to 44.3 pmol/mg Cre, Fig. 4B).”
Quote in the paperSubstantial claimMay combine two claims.
FindingreasoningThe levels of 15NO2-cLA after 15NO3− + cLA administration were lower and detectable at later time points compared to those after 15NO2− + cLA supplementation.
“The levels of 15NO2-cLA after 15NO3− + cLA administration were lower and detectable at later time points compared to those after 15NO2− + cLA supplementation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataDietary supplementation with 15NO3− and 15NO2− caused an increase of all detectable endogenous NOx species, thereby increasing 14NO2− levels that paralleled concentrations of 15NOx species.
“Notably, dietary supplementation with 15NO3− and 15NO2− caused an increase of all detectable endogenous NOx species, thereby increasing 14NO2− levels that paralleled concentrations of 15NOx species.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataThe concentration of both cLA isomers peaked at 3 h after 15NO2− + cLA administration, with (9Z,11E)-cLA averaging 858 ± 138 nM and (10E,12Z)-cLA averaging 430.3 ± 77.8 nM.
“The concentration of both isomers peaked at 3 h after 15NO2− + cLA administration with (9Z,11E)-cLA ranging from 530 to 1350 nM with an average of 858 ± 138 nM and (10E,12Z)-cLA ranging from 271 to 710 nM, with an average of 430.3 ± 77.8 nM (Fig. 3A).”
Quote in the paperNot a substantial claimMay combine two claims.
FindingcitationUrinary β-oxidation products and cysteine-adducts of 14NO2-cLA and 15NO2-cLA were measured, confirming the electrophilic reactivity of the parent molecules and metabolites.
“Urinary β-oxidation products and cysteine-adducts (Supplementary Fig. S2 and S3) of 14NO2-cLA and 15NO2-cLA were also measured, confirming the electrophilic reactivity of the parent molecules and metabolites [3].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [3] Salvatore, 2013, Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine, Journal of lipid research source
Not checked in the free run.
May combine two claims.
Findingown dataMaximum levels of plasma 15NO2− after dietary intake occurred after 30 min, thus preceding 15NO2-cLA formation.
“Maximum levels of plasma 15NO2− after dietary intake occurred after 30 min (Fig. 3C), thus preceding 15NO2-cLA formation.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the absence of cLA supplementation in combination with overnight fasting, plasma 15NO2-cLA concentrations were barely detectable and only became significantly elevated 24 h after 15NO3− consumption.
“It was hypothesized that dietary NOx would be limiting in NO2-cLA formation; however, in the absence of cLA supplementation in combination with overnight fasting, plasma 15NO2-cLA concentrations were barely detectable and only became significantly elevated 24 h after 15NO3− consumption (Fig. 2C).”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationFatty acid nitroalkene derivatives (NO2-FA) are detected in species as diverse as plants, insects and humans.
“Fatty acid nitroalkene derivatives (NO2-FA) are detected in species as diverse as plants, insects and humans [1–3], but little is known of how NO2-FA are endogenously generated.”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [1] Piskorski, 2007, Nitroalkenes and sesquiterpene hydrocarbons from the frontal gland of three prorhinotermes termite species, Journal of chemical ecology source
Not checked in the free run.
- cites [2] Fazzari, 2014, Olives and olive oil are sources of electrophilic fatty acid nitroalkenes, PLoS One source
Not checked in the free run.
- cites [3] Salvatore, 2013, Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine, Journal of lipid research source
Not checked in the free run.
Classified as probably not a substantial claim.
Study design and conductnone givenA standard curve using synthetic NO2-cLA and [13C18]-NO2-OA internal standard allowed for the quantification of endogenous products.
“A standard curve using synthetic NO2-cLA and [13C18]-NO2-OA internal standard allowed for the quantification of endogenous products.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim. May combine two claims.
Study design and conductown dataHealthy volunteers were randomized to receive either Na15NO2 (20 mg) or Na15NO3 (1 gm), and after a ~7 day washout period were crossed over to receive the other nitrogen oxide.
“Healthy volunteers fasted overnight (10–12 h) and were randomized to receive either Na15NO2 (20 mg) or Na15NO3 (1 gm). Following ~7 day washout period, volunteers were crossed over to receive the other nitrogen oxide (NOx) (Trial I).”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationMetal center-independent reactions of ·NO and nitrite (NO2−) at neutral pH yield both symmetric and asymmetric dinitrogen trioxide (N2O3), which mediates the concerted S-nitrosation of thiols and nitration of unsaturated fatty acid conjugated dienes.
“metal center-independent reactions of ·NO and nitrite (NO2−) at neutral pH yield both symmetric and asymmetric dinitrogen trioxide (N2O3), that in turn mediates the concerted S-nitrosation of thiols and nitration of unsaturated fatty acid conjugated dienes [10].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [10] Vitturi, 2015, Convergence of Biological Nitration and Nitrosation Reactions via Symmetrical Nitrous Anhydride (N2O3)
Not checked in the free run.
Classified as probably not a substantial claim. May combine two claims.
Study design and conductnone givenThe lipid extraction procedure allowed for measurement of NO2-cLA that was non-covalently bound to albumin and other proteins as well as NO2-cLA that was covalently adducted to small thiols and proteins.
“This extraction procedure allowed for measurement of NO2-cLA that was non-covalently bound to albumin and other proteins as well as the NO2-cLA that was covalently adducted to small thiols and proteins.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe bleed-over of 14N into the 15N transition has been accounted for in the calculations of the 15N contribution to total nitrite.
“Additionally, the “bleed over” of 14N into the 15N transition has been accounted for in the calculations of the 15N contribution to total nitrite.”
Quote in the paperNot a substantial claimMay combine two claims.
PremisecitationThis post-translational modification of functionally-significant hyperreactive thiols induces pleiotropic responses that include the cGMP-independent activation of transcriptional programs regulated by Nrf2 and nuclear lipid receptors, as well as inhibition of pro-inflammatory signaling by NF-kβ.
“This post-translational modification of functionally-significant hyperreactive thiols induces pleiotropic responses that include the cGMP-independent activation of transcriptional programs regulated by nuclear factor (erythroid-derived-2)-like 2 (Nrf2) and nuclear lipid receptors, as well as inhibition of pro-inflammatory signaling by nuclear factor kappa-β (NF-kβ) [12–15].”
Quote in the paperSubstantial claim0 of 4 sources checked- cites [12] Kansanen, 2009, Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid, J Biol Chem source
Not checked in the free run.
- cites [13] Kansanen, 2011, Electrophilic Nitro-fatty Acids Activate NRF2 by a KEAP1 Cysteine 151-independent Mechanism, J Biol Chem source
Not checked in the free run.
- cites [14] Schopfer, 2011, Formation and signaling actions of electrophilic lipids, Chem Rev source
Not checked in the free run.
- cites [15] Cui, 2006, Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators, J. Biol. Chem. source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductown dataThe quality and stability of the 15N-labeled sodium nitrite and sodium nitrate capsules were measured by stability-indicating HPLC assays, and all operations were performed in a GMP pharmaceutical manufacturing facility.
“The quality and stability of the capsules were measured by stability indicating HPLC assays. All operations were performed in a GMP pharmaceutical manufacturing facility with chemical analysis preformed on site.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Study design and conductnone givenThe study was performed with University of Pittsburgh IRB and FDA IND approval, and informed consent was obtained from all subjects before participation.
“This study was performed with University of Pittsburgh IRB (PRO11120134) and FDA IND (#115926) approval. Informed consent was obtained from all subjects before participation.”
Quote in the paperNot a substantial claimMay combine two claims.
Premisecitation·NO2 is formed by metalloprotein-catalyzed oxidation of NO2−, the autoxidation of ·NO, the protonation of NO2− to N2O3 followed by its disproportionation, decomposition of nitrous acid, and the homolytic scission of peroxynitrous acid and nitrosoperoxocarbonate.
“This species is formed by metalloprotein-catalyzed oxidation of NO2−, the autoxidation of ·NO, the protonation of NO2− to N2O3 followed by its disproportionation, decomposition of nitrous acid, and the homolytic scission of two key products of ·NO and superoxide (O2 ·−) reaction, peroxynitrous acid and nitrosoperoxocarbonate [21–23].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [21] Suarez, 1989, Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum, Cancer research
Not checked in the free run.
- cites [22] Leach, 1987, Bacterially catalysed N-nitrosation reactions and their relative importance in the human stomach, Carcinogenesis source
Not checked in the free run.
- cites [23] Eiserich, 1998, Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils, Nature source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationDietary sources of cLA include dairy products and meat, and cLA is also a product of enterosalivary bacterial Δ9-desaturase activity.
“Dietary sources of cLA include dairy products and meat and cLA is also a product of enterosalivary bacterial Δ9-desaturase activity [27].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [27] Churruca, 2009, Conjugated linoleic acid isomers: differences in metabolism and biological effects, BioFactors source
Not checked in the free run.
May combine two claims.
PremisecitationUnsaturated fatty acids having conjugated double bonds, such as cLA, are highly reactive with ·NO2, a reaction that occurs much more readily than tyrosine nitration.
“Unsaturated fatty acids having conjugated double bonds, such as cLA, are highly reactive with ·NO2, a reaction that occurs much more readily than tyrosine nitration [24].”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [24] Bonacci, 2012, Conjugated linoleic acid is a preferential substrate for fatty acid nitration, J Biol Chem source
Not checked in the free run.
May combine two claims.
PremisecitationThe consumption of cLA is linked with beneficial clinical responses, including the reduction of obesity-related body mass index, improved insulin sensitivity and attenuation of airway hyperactivity.
“The consumption of cLA is linked with beneficial clinical responses, including the reduction of obesity-related body mass index, improved insulin sensitivity and attenuation of airway hyperactivity, all of which we propose are due in part to the formation and signaling actions of NO2-cLA [29–32].”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [29] Tricon, 2004, Effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on immune cell function in healthy humans, The American journal of clinical nutrition source
Not checked in the free run.
- cites [30] Tricon, 2004, Opposing effects of cis-9,trans-11 and trans-10,cis-12 conjugated linoleic acid on blood lipids in healthy humans, The American journal of clinical nutrition source
Not checked in the free run.
- cites [31] MacRedmond, 2010, Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics, Clin Exp Allergy source
Not checked in the free run.
- cites [32] Zulet, 2005, Inflammation and conjugated linoleic acid: mechanisms of action and implications for human health, J Physiol Biochem source
Not checked in the free run.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe predominant endogenous cLA isomer is 9-cis, 11-trans-cLA, whereas plant-derived oils contain a racemic mixture of 9-cis, 11-trans and 10-trans, 12-cis-cLA.
“The predominant endogenous cLA isomer is 9-cis, 11-trans-cLA, whereas plant-derived oils contain a racemic mixture of 9-cis, 11-trans and 10-trans, 12-cis-cLA [28].”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [28] Kitz, 2010, Omega-3 polyunsaturated fatty acids and bronchial inflammation in grass pollen allergy after allergen challenge, Respiratory medicine source
Not checked in the free run.
May combine two claims.
PremisecitationElectrophilic nitroalkenes such as NO2-cLA induce kinetically rapid posttranslational modification of nucleophilic cysteines of key transcriptional regulatory proteins and inhibit the activity of functionally-significant electrophile-sensitive enzymes.
“Electrophilic nitroalkenes such as NO2-cLA induce kinetically rapid posttranslational modification of nucleophilic cysteines of key transcriptional regulatory proteins and inhibit the activity of functionally-significant electrophile-sensitive enzymes [11, 33, 34].”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [11] Schopfer, 2011, Formation and signaling actions of electrophilic lipids, Chem Rev source
Not checked in the free run.
- cites [33] Kelley, 2008, Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase, J Biol Chem source
Not checked in the free run.
- cites [34] Bianchini, 2009, Partitioning the relative contributions of inorganic plant composition and soil characteristics to the quality of Helichrysum italicum subsp. italicum (Roth) G. Don fil. essential oil, Chemistry & biodiversity source
Not checked in the free run.
May combine two claims.
PremisecitationNO2-cLA is found basally in the plasma and urine of healthy humans and its concentrations increase in organelles and tissues undergoing metabolic and inflammatory stress.
“NO2-cLA is found basally in the plasma and urine of healthy humans and its concentrations increase in organelles and tissues undergoing metabolic and inflammatory stress [3, 16] (Fig. 5).”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [3] Salvatore, 2013, Characterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine, Journal of lipid research source
Not checked in the free run.
- cites [16] Trapasso, 2009, Retinoids: new use by innovative drug-delivery systems, Expert opinion on drug delivery source
Not checked in the free run.
May combine two claims.
InterpretationreasoningSome of these transformations retain intrinsic signaling competency via preservation of their electrophilic moiety and others do not.
“From a pharmacological perspective, some of these transformations retain intrinsic signaling competency via preservation of their electrophilic moiety and others do not.”
Quote in the paperNot a substantial claimMay combine two claims.
InterpretationreasoningLipid nitroalkene derivatives represent salutary signaling molecules that both modulate inflammation and serve as sensitive biomarkers for tissue nitrative and nitrosative reactions.
“Thus, lipid nitroalkene derivatives represent salutary signaling molecules that both modulate inflammation and serve as sensitive biomarkers for tissue nitrative and nitrosative reactions, much like 8-iso-prostaglandin F2α is a marker for oxidative reactions.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationNitroalkylation directly inhibits the catalytic activity of enzymes including xanthine oxidoreductase, cyclooxygenase and soluble epoxide hydrolase, reactions that result in significant beneficial physiological responses.
“Nitroalkylation also directly inhibits the catalytic activity of enzymes including xanthine oxidoreductase [33], cyclooxygenase [37] and soluble epoxide hydrolase (Cys521) [34], reactions that result in significant beneficial physiological responses.”
Quote in the paperSubstantial claim0 of 3 sources checked- cites [33] Kelley, 2008, Nitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase, J Biol Chem source
Not checked in the free run.
- cites [37] Trostchansky, 2011, Nitroarachidonic acid, a novel peroxidase inhibitor of prostaglandin endoperoxide H synthases 1 and 2, J Biol Chem source
Not checked in the free run.
- cites [34] Bianchini, 2009, Partitioning the relative contributions of inorganic plant composition and soil characteristics to the quality of Helichrysum italicum subsp. italicum (Roth) G. Don fil. essential oil, Chemistry & biodiversity source
Not checked in the free run.
May combine two claims.
Interpretationown dataThe formation of NO2-cLA and its metabolites after dietary nitrogen oxide and cLA consumption reveals that diet, digestion and metabolism yield a spectrum of absorbable electrophilic metabolites that are detectable in both plasma and urine.
“In summary, the formation of NO2-cLA and its metabolites after dietary nitrogen oxide and cLA consumption reveals that diet, digestion and metabolism yield a spectrum of absorbable electrophilic metabolites that are detectable in both plasma and urine.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPreviously reported targets of nitroalkylation include Cys285 of PPARγ, Cys273 and Cys288 of Keap1, heat shock proteins, and Cys38 of the p65 subunit of NF-κB.
“Previously reported targets of nitroalkylation include the Cys285 of PPARγ (peroxisome proliferator activator receptor γ) [35], Cys273 and Cys288 of the Nrf2 regulatory protein Keap1 [Kelch-like ECH-associated protein 1 (Keap1)/regulator of nuclear factor (erythroid-derived-2)-like 2 (Nrf2)] [12], heat shock proteins[12], and Cys38 of the p65 subunit of nuclear factor κB (NF-κB) [36] (Fig. 5).”
Quote in the paperNot a substantial claim0 of 3 sources checked- cites [35] Ferreira, 2012, Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors, Free radical biology & medicine source
Not checked in the free run.
- cites [12] Kansanen, 2009, Nrf2-dependent and -independent responses to nitro-fatty acids in human endothelial cells: identification of heat shock response as the major pathway activated by nitro-oleic acid, J Biol Chem source
Not checked in the free run.
- cites [36] Cui, 2006, Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators, The Journal of biological chemistry source
Not checked in the free run.
The paper relies on this without support.
Little is known about how NO2-FA are endogenously generated.
“Fatty acid nitroalkene derivatives (NO2-FA) are detected in species as diverse as plants, insects and humans [1–3], but little is known of how NO2-FA are endogenously generated.”
The paper relies on this without support.
A gap in understanding of the beneficial systemic responses to dietary nitrate, nitrite and conjugated linoleic acid is the identification of the downstream metabolites that mediate their actions.
“A gap in our understanding of the beneficial systemic responses to dietary constituents nitrate (NO3−), nitrite (NO2−) and conjugated linoleic acid (cLA) is the identification of the downstream metabolites that mediate their actions.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
These reactions lead to generation of electrophilic nitro-fatty acid signaling mediators, including NO2-CLA and S-nitrosothiol derivatives, detected at increased concentrations in systemic circulation following oral consumption of nitrate.
“These reactions also lead to the generation of electrophilic nitro-fatty acid (NO2-FA) signaling mediators, including NO2-conjugated linoleic acid (NO2-CLA) and S-nitrosothiol derivatives, all of which can be detected at increased concentrations in the systemic circulation following oral consumption of nitrate[72,92–96].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [72]
More recent evidence in both infants and adults suggests that exceptionally high concentrations of nitrite (well beyond the <75mg nitrite necessary to achieve blood pressure effects) would be necessary to pose a significant threat to safety.
“although more recent evidence in both infants and adults suggests that exceptionally high concentrations of nitrite (and well beyond the <75mg nitrite necessary to achieve blood pressure effects) would be necessary to pose a significant threat to safety[25,51,72,113,155–158].”
From Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health (2017) · cites this paper as [72]
Cites
The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics
Lundberg, J. O., Weitzberg, E., & Gladwin, M. T. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2466 · Cited by 2,739 · cited 1× · see citing works
“The plasma half-life of NO2 is 5–6 h, also tracking with the decrease of (15)NO2-cLA in plasma between 6 and 24 h [39, 40].”
BackgroundSelf-citationFormation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils
Eiserich, J. P., Hristova, M., Cross, C. E., Jones, A. D., Freeman, B. A., Halliwell, B., & van der Vliet, A. (1998) · Nature · doi:10.1038/34923 · Cited by 1,496 · see citing works
Self-citationNitrate and nitrite in biology, nutrition and therapeutics
Lundberg, J. O., Gladwin, M. T., Ahluwalia, A., Benjamin, N., Bryan, N. S., Butler, A., Cabrales, P., Fago, A., Feelisch, M., Ford, P. C., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.260 · Cited by 617 · see citing works
Self-citationProtein Tyrosine Nitration: Biochemical Mechanisms and Structural Basis of Functional Effects
Radi, R. (2013) · Accounts of Chemical Research · doi:10.1021/ar300234c · Cited by 525 · see citing works
Nitrated Fatty Acids: Endogenous Anti-inflammatory Signaling Mediators
Cui, T., Schopfer, F. J., Zhang, J., Chen, K., Ichikawa, T., Baker Paul, R. S., Batthyany, C., Chacko, B. K., Feng, X., Patel, R. P., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603357200 · Cited by 351 · see citing works
Self-citationFormation and signaling actions of electrophilic lipids
Schopfer, F. J., Cipollina, C., & Freeman, B. A. (2011) · Chemical Reviews · doi:10.1021/cr200131e · Cited by 299 · see citing works
Self-citationHydrogen sulfide anion regulates redox signaling via electrophile sulfhydration
Nishida, M., Sawa, T., Kitajima, N., Ono, K., Inoue, H., Ihara, H., Motohashi, H., Yamamoto, M. P., Suematsu, M., Kurose, H., et al. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.1018 · Cited by 294 · see citing works
Self-citationTricon, S., Burdge, G. C., Kew, S., Banerjee, T., Russell, J. J., Jones, E. L., Grimble, R. F., Williams, C. M., Yaqoob, P., & Calder, P. C. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.3.614 · Cited by 294 · see citing works
Measurement of circulating nitrite and S-nitrosothiols by reductive chemiluminescence
MacArthur, P. H., Shiva, S., & Gladwin, M. T. (2007) · Journal of Chromatography B · doi:10.1016/j.jchromb.2006.12.012 · Cited by 229 · see citing works
Self-citationElectrophilic nitro-fatty acids activate NRF2 by a KEAP1 cysteine 151-independent mechanism
Kansanen, E., Bonacci, G., Schopfer, F. J., Kuosmanen, S. M., Tong, K. I., Leinonen, H., Woodcock, S. R., Yamamoto, M., Carlberg, C., Ylä-Herttuala, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.190710 · Cited by 208 · see citing works
Self-citation(1983) · PubMed · Cited by 202 · see citing works
Nrf2-dependent and -independent Responses to Nitro-fatty Acids in Human Endothelial Cells
Kansanen, E., Jyrkkänen, H.-K., Volger, O. L., Leinonen, H., Kivelä, A. M., Häkkinen, S.-K., Woodcock, S. R., Schopfer, F. J., Horrevoets, A. J., Ylä-Herttuala, S., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064873 · Cited by 165 · see citing works
Self-citationConjugated linoleic acid isomers: differences in metabolism and biological effects
Churruca, I., Fernández‐Quintela, A., & Portillo, M. P. (2009) · BioFactors · doi:10.1002/biof.13 · Cited by 160 · see citing works
Conjugated linoleic acid is a preferential substrate for fatty acid nitration
Bonacci, G., Baker, P. R. S., Salvatore, S. R., Shores, D., Khoo, N. K. H., Koenitzer, J. R., Vitturi, D. A., Woodcock, S. R., Golin-Bisello, F., Cole, M. P., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401356 · Cited by 147 · see citing works
Self-citationNitro-oleic acid inhibits angiotensin II-induced hypertension
Zhang, J., Villacorta, L., Chang, L., Fan, Z., Hamblin, M., Zhu, T., Chen, C. S., Cole, M. P., Schopfer, F. J., Deng, C. X., et al. (2010) · Circulation Research · doi:10.1161/circresaha.110.218404 · Cited by 121 · see citing works
Self-citationVillacorta, L., Chang, L., Salvatore, S. R., Ichikawa, T., Zhang, J., Petrovic-Djergovic, D., Jia, L., Carlsen, H., Schopfer, F. J., Freeman, B. A., et al. (2013) · Cardiovascular Research · doi:10.1093/cvr/cvt002 · Cited by 116 · see citing works
Self-citationNitro-fatty Acid Metabolome: Saturation, Desaturation, β-Oxidation, and Protein Adduction
Rudolph, V., Schopfer, F. J., Khoo, N. K. H., Rudolph, T. K., Cole, M. P., Woodcock, S. R., Bonacci, G., Groeger, A. L., Golin-Bisello, F., Chen, C.-S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802298200 · Cited by 115 · see citing works
Self-citationOlives and olive oil are sources of electrophilic fatty acid nitroalkenes
Fazzari, M., Trostchansky, A., Schopfer, F. J., Salvatore, S. R., Sánchez-Calvo, B., Vitturi, D., Valderrama, R., Barroso, J. B., Radi, R., Freeman, B. A., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0084884 · Cited by 114 · see citing works
Self-citationTricon, S., Burdge, G. C., Kew, S., Banerjee, T., Russell, J. J., Grimble, R. F., Williams, C. M., Calder, P. C., & Yaqoob, P. (2004) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1626 · Cited by 111 · see citing works
Leach, S. A., Thompson, M., & Hill, M. (1987) · Carcinogenesis · doi:10.1093/carcin/8.12.1907 · Cited by 97 · see citing works
Kelley, E. E., Baust, J., Bonacci, G., Golin-Bisello, F., Devlin, J. E., St. Croix, C. M., Watkins, S. C., Gor, S., Cantu-Medellin, N., Weidert, E. R., et al. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvt341 · Cited by 95 · see citing works
Self-citationNitrated oleic acid up-regulates PPARγ and attenuates experimental inflammatory bowel disease
Borniquel, S., Jansson, E. Å., Cole, M. P., Freeman, B. A., & Lundberg, J. O. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.11.014 · Cited by 92 · see citing works
Self-citationCharacterization and quantification of endogenous fatty acid nitroalkene metabolites in human urine
Salvatore, S. R., Vitturi, D. A., Baker, P. R. S., Bonacci, G., Koenitzer, J. R., Woodcock, S. R., Freeman, B. A., & Schopfer, F. J. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m037804 · Cited by 82 · see citing works
Self-citationNitro-oleic Acid, a Novel and Irreversible Inhibitor of Xanthine Oxidoreductase
Kelley, E. E., Batthyany, C. I., Hundley, N. J., Woodcock, S. R., Bonacci, G., Del Rio, J. M., Schopfer, F. J., Lancaster, J. R., Freeman, B. A., & Tarpey, M. M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802402200 · Cited by 81 · see citing works
Self-citationChromý, V., Rozkošná, K., & Sedlák, P. (2008) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2008.224 · Cited by 79 · see citing works
Khoo, N. K. H., Rudolph, V., Cole, M. P., Golin-Bisello, F., Schopfer, F. J., Woodcock, S. R., Batthyany, C., & Freeman, B. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.10.046 · Cited by 79 · see citing works
Self-citationModulation of Nitro-fatty Acid Signaling
Vitturi, D. A., Chen, C.-S., Woodcock, S. R., Salvatore, S. R., Bonacci, G., Koenitzer, J. R., Stewart, N. A., Wakabayashi, N., Kensler, T. W., Freeman, B. Α., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.486282 · Cited by 75 · see citing works
Self-citationConvergence of biological nitration and nitrosation via symmetrical nitrous anhydride
Vitturi, D. A., Minarrieta, L., Salvatore, S. R., Postlethwait, E. M., Fazzari, M., Ferrer-Sueta, G., Lancaster, J. R., Freeman, B. A., & Schopfer, F. J. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1814 · Cited by 65 · see citing works
Self-citationInflammation and conjugated linoleic acid: mechanisms of action and implications for human health
Zulet, M. A., Marti, A., Parra, M. D., & Martínez, J. A. (2005) · Journal of Physiology and Biochemistry · doi:10.1007/bf03168454 · Cited by 62 · see citing works
(2019) · Nature Chemical Biology · doi:10.1038/41589.1552-4469 · Cited by 61 · see citing works
Trostchansky, A., Bonilla, L., Thomas, C. P., O'Donnell, V. B., Marnett, L. J., Radi, R., & Rubbo, H. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.154518 · Cited by 58 · see citing works
Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
Suarez, H. G., Daya–Grosjean, L., Schlaifer, D., Nardeux, P., Renault, G., Bos, J. L., & Sarasin, A. R. (1989) · PubMed · Cited by 54 · see citing works
Retinoids: new use by innovative drug-delivery systems
Trapasso, E., Cosco, D., Celia, C., Fresta, M., & Paolino, D. (2009) · Expert Opinion on Drug Delivery · doi:10.1517/17425240902832827 · Cited by 49 · see citing works
Conjugated linoleic acid improves airway hyper-reactivity in overweight mild asthmatics
MacRedmond, R., Singhera, G., Attridge, S., Bahzad, M., Fava, C., Lai, Y., Hallstrand, T. S., & Dorscheid, D. R. (2010) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2010.03531.x · Cited by 49 · see citing works
Conjugated linoleic acid content of human plasma
Zlatanos, S. N., Laskaridis, K., & Sagredos, A. (2008) · Lipids in Health and Disease · doi:10.1186/1476-511x-7-34 · Cited by 47 · see citing works
Oxygen Regulates Tissue Nitrite Metabolism
Curtis, E., Hsu, L. L., Noguchi, A. C., Geary, L., & Shiva, S. (2012) · Antioxidants & Redox Signaling · doi:10.1089/ars.2011.4242 · Cited by 46 · cited 3× · see citing works
“Plasma NO2 levels after 15NOx supplementation were determined for both trials using both chemiluminescence and tri-iodide-based reactions (Supplementary Fig S1A and B) [18, 19].”
MethodSelf-citationPiskorski, R., Hanus, R., Vašíčková, S., Cvačka, J., Šobotník, J., Svatoš, A., & Valterová, I. (2007) · Journal of Chemical Ecology · doi:10.1007/s10886-007-9341-y · Cited by 44 · see citing works
Kitz, R., Rose, M. A., Schubert, R., Beermann, C., Kaufmann, A., Böhles, H. J., Schulze, J., & Zielen, S. (2010) · Respiratory Medicine · doi:10.1016/j.rmed.2010.06.019 · Cited by 44 · see citing works
The nitrated fatty acid 10-nitro-oleate attenuates allergic airway disease
Reddy, A. T., Lakshmi, S. P., Dornadula, S., Pinni, S., Rampa, D. R., & Reddy, R. C. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1300730 · Cited by 42 · see citing works
Bianchini, A., Santoni, F., Paolini, J., Bernardini, A., Mouillot, D., & Costa, J. (2009) · Chemistry & Biodiversity · doi:10.1002/cbdv.200800328 · Cited by 41 · see citing works
Evaluation of an LC–MS/MS assay for 15N-nitrite for cellular studies of l-arginine action
Shin, S., & Fung, H. (2011) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2011.08.017 · Cited by 22 · see citing works
Nitro-fatty acids as novel electrophilic ligands for peroxisome proliferator-activated receptors
Ferreira, A. M., Minarrieta, L., Lamas Bervejillo, M., & Rubbo, H. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.08.572 · Cited by 16 · see citing works
The reactions of nitrogen dioxide with dienes
Claridge, R. P., Deeming, A. J., Paul, N., Tocher, D. A., & Ridd, J. H. (1998) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/a806451b · Cited by 15 · see citing works
Flagged first, then by citations
1 of the 44 references couldn’t be matched to a known paper.
Research works printed but not linked: 2
- Schopfer, 2011, Formation and signaling actions of electrophilic lipids, Chem Rev, 111, 5997, 10.1021/cr200131e · DOI · Paper page
- Cui, 2006, Nitrated fatty acids: Endogenous anti-inflammatory signaling mediators, The Journal of biological chemistry, 281, 35686, 10.1074/jbc.m603357200 · DOI · Paper page
Cited by
Sorted by citations
Metabolic Effects of Dietary Nitrate in Health and Disease
Lundberg, J. O., Carlström, M., & Weitzberg, E. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.06.007 · Cited by 374 · see citing works
den Hartigh, L. (2019) · Nutrients · doi:10.3390/nu11020370 · Cited by 371 · see citing works
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 357 · see citing works
Oduro, P. K., Zheng, X., Wei, J., Yang, Y., Wang, Y., Zhang, H., Liu, E., Gao, X., Du, M., & Wang, Q. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.05.011 · Cited by 349 · see citing works
Hansen, A. L., Buchan, G. J., Rühl, M., Mukai, K., Salvatore, S. R., Ogawa, E., Andersen, S. D., Iversen, M. B., Thielke, A. L., Gunderstofte, C., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1806239115 · Cited by 309 · see citing works
Self-citationAntioxidant Therapy in Cancer: Rationale and Progress
Luo, M., Zhou, L., Huang, Z., Li, B., Nice, E. C., Xu, J., & Huang, C. (2022) · Antioxidants · doi:10.3390/antiox11061128 · Cited by 201 · see citing works
Koch, C. D., Gladwin, M. T., Freeman, B. A., Lundberg, J. O., Weitzberg, E., & Morris, A. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.12.015 · Cited by 186 · see citing works
Self-citationSTING palmitoylation as a therapeutic target
Hansen, A. L., Mukai, K., Schopfer, F. J., Taguchi, T., & Holm, C. K. (2019) · Cellular and Molecular Immunology · doi:10.1038/s41423-019-0205-5 · Cited by 98 · see citing works
Self-citationThe solution chemistry of nitric oxide and other reactive nitrogen species
Ford, P. C., & Miranda, K. M. (2020) · Nitric Oxide · doi:10.1016/j.niox.2020.07.004 · Cited by 100 · see citing works
Beyond the Lungs: Systemic Manifestations of Pulmonary Arterial Hypertension
Nickel, N. P., Yuan, K., Dorfmüller, P., Provencher, S., Lai, Y., Bonnet, S., Austin, E. D., Koch, C. D., Morris, A. M., Perros, F., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201903-0656ci · Cited by 99 · see citing works
Mechanisms underlying blood pressure reduction by dietary inorganic nitrate
Carlström, M., Lundberg, J. O., & Weitzberg, E. (2018) · Acta Physiologica · doi:10.1111/apha.13080 · Cited by 86 · see citing works
Woodcock, C.-. C., Huang, Y., Woodcock, S. R., Salvatore, S. R., Singh, B., Golin-Bisello, F., Davidson, N. E., Neumann, C. A., Freeman, B. Α., & Wendell, S. G. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.814368 · Cited by 72 · see citing works
Self-citationVillacorta, L., Minarrieta, L., Salvatore, S. R., Khoo, N. K. H., Rom, O., Gao, Z., Berman, R. C., Jobbagy, S., Li, L., Woodcock, S. R., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.01.005 · Cited by 71 · see citing works
Self-citationNitro-Fatty Acid Logistics: Formation, Biodistribution, Signaling, and Pharmacology
Schopfer, F. J., & Khoo, N. K. H. (2019) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2019.04.009 · Cited by 67 · see citing works
Self-citationModulatory role of dietary polyunsaturated fatty acids in Nrf2-mediated redox homeostasis
Abrescia, P., Treppiccione, L., Rossi, M., & Bergamo, P. (2020) · Progress in Lipid Research · doi:10.1016/j.plipres.2020.101066 · Cited by 64 · see citing works
Khoo, N. K. H., Li, L., Salvatore, S. R., Schopfer, F. J., & Freeman, B. Α. (2018) · Scientific Reports · doi:10.1038/s41598-018-20460-8 · Cited by 63 · see citing works
Self-citationTurell, L., Vitturi, D. A., Coitiño, E. L., Lebrato, L., Möller, M. N., Sagasti, C., Salvatore, S. R., Woodcock, S. R., Álvarez, B., & Schopfer, F. J. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.756288 · Cited by 60 · see citing works
Self-citationBervejillo, M. L., Bonanata, J. N., Franchini, G. R., Richeri, A., Marqués, J. M., Freeman, B. Α., Schopfer, F. J., Coitiño, E. L., Córsico, B., Rubbo, H., et al. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101376 · Cited by 59 · see citing works
Self-citationNitro-fatty acid pharmacokinetics in the adipose tissue compartment
Fazzari, M., Khoo, N., Woodcock, S. R., Jorkasky, D. K., Li, L., Schopfer, F. J., & Freeman, B. Α. (2016) · Journal of Lipid Research · doi:10.1194/jlr.m072058 · Cited by 49 · see citing works
Self-citationNitro-fatty acid formation and metabolism
Buchan, G. J., Bonacci, G., Fazzari, M., Salvatore, S. R., & Wendell, S. G. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.07.003 · Cited by 49 · see citing works
Self-citationPiesche, M., Roos, J., Kuhn, B. R., Fettel, J., Hellmuth, N., Brat, C., Maucher, I. V., Awad, O., Matrone, C., Comerma-Steffensen, S., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01297 · Cited by 44 · see citing works
Freeman, B. Α., O’Donnell, V. B., & Schopfer, F. J. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.05.002 · Cited by 43 · see citing works
Self-citationMelo, T., Montero‐Bullón, J., Domingues, P. M., & Domingues, M. R. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101106 · Cited by 44 · see citing works
Halade, G. V., Black, L. M., & Verma, M. K. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.02.014 · Cited by 40 · see citing works
Fazzari, M., Vitturi, D. A., Woodcock, S. R., Salvatore, S. R., Freeman, B. Α., & Schopfer, F. J. (2018) · Journal of Lipid Research · doi:10.1194/jlr.m088815 · Cited by 39 · see citing works
Self-citationThe role of dietary nitrate and the oral microbiome on blood pressure and vascular tone
Alzahrani, H., Jackson, K. G., Hobbs, D. A., & Lovegrove, J. A. (2020) · Nutrition Research Reviews · doi:10.1017/s0954422420000281 · Cited by 37 · see citing works
Evaluation of 10-Nitro Oleic Acid Bio-Elimination in Rats and Humans
Salvatore, S. R., Vitturi, D. A., Fazzari, M., Jorkasky, D. K., & Schopfer, F. J. (2017) · Scientific Reports · doi:10.1038/srep39900 · Cited by 36 · see citing works
Self-citationGut microbiota mediated the toxicity of high concentration of dietary nitrite in C57BL/6 mice
Xu, J., Wang, M., Liu, Q., Lin, X., Pu, K., & He, Z. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113224 · Cited by 35 · see citing works
Nitrated fatty acids: from diet to disease
Khoo, N., & Schopfer, F. (2019) · Current Opinion in Physiology · doi:10.1016/j.cophys.2019.04.013 · Cited by 31 · see citing works
Self-citationRocha, B. S. (2021) · Frontiers in Aging · doi:10.3389/fragi.2021.778467 · Cited by 30 · see citing works
Role of nitrite, urate and pepsin in the gastroprotective effects of saliva
Rocha, B. S., Lundberg, J. O., Radí, R., & Laranjinha, J. A. N. (2016) · Redox Biology · doi:10.1016/j.redox.2016.04.002 · Cited by 29 · see citing works
Nitro Fatty Acids (NO2-FAs): An Emerging Class of Bioactive Fatty Acids
Koutoulogenis, G. S., & Kokotos, G. (2021) · Molecules · doi:10.3390/molecules26247536 · Cited by 26 · see citing works
Conjugated Linoleic Acid Modulates Clinical Responses to Oral Nitrite and Nitrate
Hughan, K. S., Wendell, S. G., Delmastro-Greenwood, M. M., Helbling, N. L., Corey, C. G., Bellavia, L., Potti, G. K., Grimes, G. J., Goodpaster, B. H., Kim‐Shapiro, D. B., et al. (2017) · Hypertension · doi:10.1161/hypertensionaha.117.09016 · Cited by 26 · see citing works
Self-citationFatty acid nitroalkene reversal of established lung fibrosis
Koudelka, A., Cechova, V., Rojas, M. M., Mitash, N., Bondonese, A., Croix, C. M. S., Ross, M. A., & Freeman, B. Α. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102226 · Cited by 25 · see citing works
Self-citationMass spectrometry-based study defines the human urine nitrolipidome
Salvatore, S. R., Rowart, P., & Schopfer, F. J. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.10.305 · Cited by 23 · see citing works
Self-citationNitrite potentiates the vasodilatory signaling of S-nitrosothiols
Liu, T., Zhang, M., Terry, M. H., Schroeder, H. J., Wilson, S. M., Power, G. G., Li, Q., Tipple, T. E., Borchardt, D., & Blood, A. B. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.01.011 · Cited by 23 · see citing works
Kuhn, B. R., Brat, C., Fettel, J., Hellmuth, N., Maucher, I. V., Bulut, U., Hock, K. J., Grimmer, J., Manolikakes, G., Rühl, M., et al. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.06.014 · Cited by 24 · see citing works
Development of nitroalkene-based inhibitors to target STING-dependent inflammation
Chang, F., Gunderstofte, C., Colussi, N., Pitts, M., Salvatore, S. R., Thielke, A. L., Turell, L., Álvarez, B., Goldbach‐Mansky, R. T., Villacorta, L., et al. (2024) · Redox Biology · doi:10.1016/j.redox.2024.103202 · Cited by 23 · see citing works
Self-citationD’Amore, A., Fazzari, M., Jiang, H., Luketich, S. K., Luketich, M. E., Hoff, R., Jacobs, D. L., Gu, X., Badylak, S. F., Freeman, B. Α., et al. (2017) · Tissue Engineering Part A · doi:10.1089/ten.tea.2017.0349 · Cited by 23 · see citing works
Self-citationLu, H., Sun, J., Liang, W., Zhang, J., Rom, O., Garcia-Barrio, M. T., Li, S., Villacorta, L., Schopfer, F. J., Freeman, B. Α., et al. (2019) · Physiological Genomics · doi:10.1152/physiolgenomics.00127.2018 · Cited by 23 · see citing works
Self-citationThe chemical foundations of nitroalkene fatty acid signaling through addition reactions with thiols
Turell, L., Steglich, M., & Álvarez, B. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.014 · Cited by 22 · see citing works
Begara-Morales, J. C., Mata-Pérez, C., Padilla, M. N., Chaki, M., Valderrama, R., Aranda‐Caño, L., & Barroso, J. B. (2020) · Journal of Experimental Botany · doi:10.1093/jxb/eraa517 · Cited by 21 · see citing works
Nitro-fatty acids as activators of hSIRT6 deacetylase activity
Carreño, M., Bresque, M., Machado, M. R., Santos, L., Durán, R., Vitturi, D. A., Escande, C., & Denicola, A. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.014883 · Cited by 20 · see citing works
Self-citationLipid nitroalkene nanoparticles for the focal treatment of ischemia reperfusion
Yu, G. Z., Ramasamy, T., Fazzari, M., Chen, X., Freeman, B. Α., & Pacella, J. J. (2021) · Nanotheranostics · doi:10.7150/ntno.62351 · Cited by 20 · see citing works
Self-citationNeuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
Maio, R. D., Keeney, M. T., Cechova, V., Mortimer, A. D., Sekandari, A., Rowart, P., Greenamyre, J. T., Freeman, B. Α., & Fazzari, M. (2023) · npj Parkinson s Disease · doi:10.1038/s41531-023-00502-3 · Cited by 18 · see citing works
Self-citationZhao, Y., Chang, Z., Zhao, G., Lu, H., Xiong, W., Liang, W., Wang, H. H., Villacorta, L., Garcia-Barrio, M. T., Zhu, T., et al. (2020) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-020-07031-8 · Cited by 18 · see citing works
Self-citationTopical electrophilic nitro-fatty acids potentiate cutaneous inflammation
Mathers, A. R., Carey, C. D., Killeen, M. E., Salvatore, S. R., Ferris, L. K., Freeman, B. Α., Schopfer, F. J., & Falo, L. D. (2017) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2017.11.009 · Cited by 17 · see citing works
Self-citationFazzari, M., Woodcock, S. R., Rowart, P., Ricart, K. C., Lancaster, J. R., Patel, R. P., Vitturi, D. A., Freeman, B. Α., & Schopfer, F. J. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101913 · Cited by 16 · see citing works
Self-citationTherapeutic Implications of Nitrite in Hypertension
Ling, W. C., Mustafa, M. R., & Murugan, D. D. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000771 · Cited by 14 · see citing works
Nitro-fatty acids: electrophilic signaling molecules in plant physiology
Fino, L. M. D., Palma, A. A. D., Perk, E. A., García‐Mata, C., Schopfer, F. J., & Laxalt, A. M. (2021) · Planta · doi:10.1007/s00425-021-03777-z · Cited by 13 · see citing works
Self-citationFatty acid nitroalkenes – Multi-target agents for the treatment of sickle cell disease
Chowdhury, F. A., Colussi, N., Sharma, M., Wood, K. C., Xu, J. Z., Freeman, B. Α., Schopfer, F. J., & Straub, A. C. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102941 · Cited by 12 · see citing works
Self-citationThe chemical biology of dinitrogen trioxide
Möller, M. N., & Vitturi, D. A. (2024) · Redox Biochemistry and Chemistry · doi:10.1016/j.rbc.2024.100026 · Cited by 13 · see citing works
Self-citationNitro-fatty acids: promising agents for the development of new cancer therapeutics
Roos, J., Manolikakes, G., Schlomann, U., Klinke, A., Schopfer, F. J., Neumann, C. A., & Maier, T. J. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.09.009 · Cited by 13 · see citing works
Self-citationMüller, M., Schubert, T., Welke, C., Maske, T., Patschkowski, T., Donhauser, E., Heinen‐Weiler, J., Hormann, F.-L., Heiles, S., Schulz, T. J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59192-5 · Cited by 13 · see citing works
Self-citationNitric Oxide Formation From Inorganic Nitrate
Lundberg, J. O., & Weitzberg, E. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00012-0 · Cited by 12 · see citing works
Cho, H.-J., Switzer, C., Kamynina, A., Charles, R. L., Rudyk, O., Ng, T., Burgoyne, J. R., & Eaton, P. (2019) · Redox Biology · doi:10.1016/j.redox.2019.101405 · Cited by 13 · see citing works
Dietary nitrite induces occludin nitration in the stomach
Rocha, B. S., Correia, M. G., Fernandes, R. C., Gonçalves, J. S., & Laranjinha, J. A. N. (2016) · Free Radical Research · doi:10.1080/10715762.2016.1234049 · Cited by 13 · see citing works
Effects of Cooking Conditions on the Relationships Among Oxalate, Nitrate, and Lutein in Spinach
Wang, Z., Ando, A., Takeuchi, A., & Ueda, H. (2018) · Food Science and Technology Research · doi:10.3136/fstr.24.421 · Cited by 12 · see citing works
Liu, Y., Li, Y., Xue, L., Xiao, J., Li, P., Xue, W., Li, C., Guo, H., & Chen, Y. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1033982 · Cited by 10 · see citing works
Hellmuth, N., Brat, C., Awad, O., George, S., Kahnt, A. S., Bauer, T., Phuoc, H. P. H., Steinhilber, D., Angioni, C., Hassan, M. E., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.715076 · Cited by 11 · see citing works
(Poly)phenols and nitrolipids: Relevant participants in nitric oxide metabolism
Fraga, C. G., Trostchansky, A., Rocha, B. S., Laranjinha, J. A. N., Rubbo, H., & Galleano, M. (2022) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2022.101158 · Cited by 11 · see citing works
Vitturi, D. A., Maynard, C. C., Olsufka, M., Straub, A. C., Krehel, N., Kudenchuk, P. J., Nichol, G., Sayre, M. R., Kim, F., & Dezfulian, C. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101463 · Cited by 10 · see citing works
Self-citationHong, L. T., Braden, D., Zhao, Y., Skoko, J., Chang, F., Woodcock, S. R., Uvalle, C. E., Casey, A. N., Wood, K. C., Salvatore, S. R., et al. (2023) · Redox Biology · doi:10.1016/j.redox.2023.102856 · Cited by 10 · see citing works
Self-citationRocha, B. S., Nunes, C., & Laranjinha, J. A. N. (2016) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2016.10.021 · Cited by 10 · see citing works
Li, S., Chang, Z., Zhu, T., Villacorta, L., Li, Y., Freeman, B. Α., Chen, Y., & Zhang, J. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00090.2017 · Cited by 9 · see citing works
Self-citationReis, A., Rocha, B. S., Laranjinha, J. A. N., & de Freitas, V. A. P. (2024) · FEBS Letters · doi:10.1002/1873-3468.14812 · Cited by 8 · see citing works
Paiva, B., Laranjinha, J. A. N., & Rocha, B. S. (2024) · FEBS Letters · doi:10.1002/1873-3468.14859 · Cited by 11 · see citing works
Beckel, J. M., & de Groat, W. C. (2018) · Nitric Oxide · doi:10.1016/j.niox.2018.03.015 · Cited by 8 · see citing works
Streamlined One‐Pot Synthesis of Nitro Fatty Acids
Hassan, M. E., Krieg, S., Nde, C. N., Roos, J., Maier, T. J., Rady, E. A. E., Raslan, M. A.-E., Sadek, K. U., & Manolikakes, G. (2021) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202100247 · Cited by 8 · see citing works
Salvatore, S. R., Gómez‐Cortés, P., Rowart, P., Woodcock, S. R., de la Fuente, M. Á., Chang, F., & Schopfer, F. J. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.137767 · Cited by 7 · see citing works
Self-citationFreeman, B. Α., Pekarová, M., Rubbo, H., & Trostchansky, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-804273-1.00016-8 · Cited by 7 · see citing works
Self-citationNitro-fatty acids: mechanisms of action, roles in metabolic diseases, and therapeutics
Ni, H., Tan, X., Du, J., & Wang, Y. (2024) · Current Medicine · doi:10.1007/s44194-024-00030-z · Cited by 6 · see citing works
Colussi, N., Chang, F., & Schopfer, F. J. (2024) · Redox Biochemistry and Chemistry · doi:10.1016/j.rbc.2024.100037 · Cited by 5 · see citing works
Self-citationRelease of nitric oxide from nitrated fatty acids: Insights from computational chemistry
Su, Y., Wu, S., & Hu, C. (2018) · Journal of the Chinese Chemical Society · doi:10.1002/jccs.201800136 · Cited by 5 · see citing works
Nitro fatty acids: A comprehensive review on analytical methods and levels in health and disease
Elshoura, Y., Herz, M., Gad, M. Z., & Hanafi, R. S. (2024) · Analytical Biochemistry · doi:10.1016/j.ab.2024.115624 · Cited by 5 · see citing works
Ledo, A., Rocha, B. S., & Laranjinha, J. A. N. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-11488-6_10 · Cited by 4 · see citing works
Effects of fatty acid nitroalkanes on signal transduction pathways and airway macrophage activation
Wilkinson, M. L., & Gow, A. J. (2021) · Innate Immunity · doi:10.1177/17534259211015330 · Cited by 4 · see citing works
Lee, J. E., Lee, A., Choi, E., Choi, I.-S., & Kim, S.-J. (2023) · InflammoPharmacology · doi:10.1007/s10787-023-01340-8 · Cited by 3 · see citing works
Wang, Z., Ando, A., Takeuchi, A., & Ueda, H. (2019) · Food Science and Technology Research · doi:10.3136/fstr.25.801 · Cited by 3 · see citing works
Woodcock, S. R., Salvatore, S. R., Freeman, B. Α., & Schopfer, F. J. (2021) · Tetrahedron Letters · doi:10.1016/j.tetlet.2021.153371 · Cited by 3 · see citing works
Self-citationHuman glutathione transferases catalyze the reaction between glutathione and nitrooleic acid
Steglich, M., Larrieux, N., Zeida, A., Rizza, J. D., Salvatore, S. R., Bonilla, M., Möller, M. N., Buschiazzo, A., Álvarez, B., Schopfer, F. J., et al. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.108362 · Cited by 3 · see citing works
Self-citationNitro-fatty acid signaling and intracellular biodistribution in plants
Aranda‐Caño, L., Valderrama, R., Begara-Morales, J. C., Chaki, M., Pedrajas, J. R., & Barroso, J. B. (2025) · Plant Science · doi:10.1016/j.plantsci.2025.112829 · Cited by 2 · see citing works
Alzahrani, H. S., McKenna, H. B., Hobbs, D. A., Jackson, K. G., & Lovegrove, J. A. (2025) · Journal of Nutrition · doi:10.1016/j.tjnut.2025.11.018 · Cited by 2 · see citing works
Liu, W., Cao, S., Guo, Y., Gao, Y., Zhang, X., Shi, D., & Huang, L. (2025) · Environmental Pollution · doi:10.1016/j.envpol.2025.126929 · Cited by 2 · see citing works
Thiol modification and signaling by biological electrophiles
Schopfer, F. J., & Vitturi, D. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90219-9.00027-3 · Cited by 1 · see citing works
Self-citationStevenson, E. R., O’Brien, J. P., Manuel, A. M., Uvalle, C. E., Buchan, G. J., Mullett, S. J., Lockwood, K. C., Suber, T. L., Freeman, B. Α., & Gelhaus, S. L. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1426102 · Cited by 1 · see citing works
Self-citationNeuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease.Preprint
Fazzari, M., Maio, R. D., Keeney, M. T., Cechova, V., Mortimer, A. D., Rowart, P., Greenamyre, J. T., & Freeman, B. Α. (2022) · Research Square · doi:10.21203/rs.3.rs-2367066/v1 · Cited by 1 · see citing works
Self-citationMüller, M., Schubert, T., Welke, C., Schulz, T. J., Patschkowski, T., Maske, T., Lengenfelder, L. A., Landwehrjohann, L., Donhauser, E., Vogt, E. T., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.20.581137 · Cited by 1 · see citing works
Self-citationRoy, S., Proffer, M. L., Syed, F., Smithmyer, M. E., Sharma, A. R., Twoy, A., Soohoo, E., Rana, J., Spaeth, J. M., Meyer, E. H., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.02.10.705171 · Cited by 1 · see citing works
Durand, G. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch21
NITROALKENE FATTY ACIDS: FORMATION, METABOLISM, REACTIVITY, AND SIGNALING
Steglich, M., Sosa, M., Schopfer, F. J., & Turell, L. (2025) · Wiley eBooks · doi:10.1002/9781119790419.ch20
Self-citationLin, Y., Chen, R., Ge, Y., Liu, X., Chung, K. F., & Zhang, J. J. (2025) · Environment & Health · doi:10.1021/envhealth.5c00068
Rodríguez, L., Fernandez-Rojas, M., Morales-Malvarez, L., Eduardo Fuentes, Q., & Trostchansky, A. (2025) · Food Bioscience · doi:10.1016/j.fbio.2025.108175
Nitrated fatty acids form membrane biochemical capacitors that restrain inflammation
Colussi, N., Salvatore, S. R., Vazquez, M., Gutierrez, M. V., Hahn, S., Ricart, K. C., Vendrame, F., Badino, M., Schopfer, A. L., Vitturi, D. A., et al. (2026) · Cell chemical biology · doi:10.1016/j.chembiol.2026.08.002
Self-citationAranda‐Caño, L., Valderrama, R., Chaki, M., Begara-Morales, J. C., Pedrajas, J. R., Melguizo, M., Moret, M., Bombarely, A., Luque, F., & Barroso, J. B. (2026) · Plant Cell & Environment · doi:10.1111/pce.70956
Endothelial nitric oxide signaling in cellular and systemic metabolism
Siragusa, M., Dunaway, L. S., Lammert, E., Fleming, I., Isakson, B. E., & Cortese-Krott, M. M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104443
- Authors
- Delmastro-Greenwood, M., Hughan, K. S., Vitturi, D. A., Salvatore, S. R., Grimes, G., Potti, G., Shiva, S., Schopfer, F. J., Gladwin, M. T., Freeman, B. A., & Gelhaus Wendell, S.
- Affiliations
- University of Pittsburgh (US)
- National Institutes of Health (US)
- ORCID
- Venue
- Free Radical Biology and Medicine
- Publisher
- Elsevier BV
- Published
- 2015-12
- Volume
- 89
- Pages
- 333-341
- ISSN
- 0891-5849 (ISSN-L)
- PMC
- PMC4684780
- OpenAlex
- W1743854985
- Semantic Scholar
- f7888ccca45b1a0ee2c17225873bd39a5a520cb6
- Cited by
- 97
- References
- 44
- Citations by year
- 2026: 4 · 2025: 10 · 2024: 9 · 2023: 5 · 2022: 6 · 2021: 11 · 2020: 9 · 2019: 12 · 2018: 17 · 2017: 7 · 2016: 6 · 2015: 1
- FWCI
- 9.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Free Radical Biology and Medicine (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- NIH (R01-HL058115, R01-HL64937 (BF), P01-HL103455 (MG, BF), AT00682 (FJS), K12-HD052892 (KSH))
- Topics
- Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Keywords
- nitrite, nitrate, conjugated linoleic acid, Michael addition, post-translational modification, nitric oxide, nitrate supplementation, anti-inflammatory activity, 15N-labelled nitrate
- MeSH terms
- Adult, Alkenes, Anti-Inflammatory Agents, Chromatography, Liquid, Female, Humans, Male, Nitrates, Nitrites, Nitro Compounds, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Dietary Supplements, Linoleic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-09.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-09.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review